false
OasisLMS
Catalog
SCCM Resource Library
AED Prophylaxis: Treating Something That Isn't The ...
AED Prophylaxis: Treating Something That Isn't There
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Sean Rowe, an associate professor of clinical pharmacy, discusses the Neurocritical Care Guidelines for the use of anti-seizure drugs for seizure prophylaxis. He explains the guideline process, which involves developing clinical questions, conducting systematic reviews, and synthesizing evidence. The guideline focuses on four disease states: traumatic brain injury, aneurysmal subarachnoid hemorrhage, intracerebral hemorrhage, and supratentorial surgery. Rowe presents the results of the meta-analyses conducted for each disease state, highlighting the lack of statistical difference in preventing early seizures, late seizures, mortality, and adverse events in traumatic brain injury. He also notes that there was a worse outcome in functional outcome for patients with intracerebral hemorrhage who received anti-seizure drugs. In supratentorial surgery, levitiracetam showed an improvement in preventing early seizures compared to phenytoin. The committee is currently working on the final recommendations and plans to publish them throughout the year.
Asset Subtitle
Quality and Patient Safety, 2023
Asset Caption
Type: one-hour concurrent | Guideline Review: Status Epilepticus and Seizure Prophylaxis (SessionID 1119989)
Meta Tag
Content Type
Presentation
Knowledge Area
Quality and Patient Safety
Membership Level
Professional
Membership Level
Select
Tag
Evidence Based Medicine
Year
2023
Keywords
Neurocritical Care Guidelines
Anti-seizure drugs
Seizure prophylaxis
Disease states
Meta-analyses
×
Please select your language
1
English